ArticleClinical ophthalmology (Auckland, N.Z.)2025

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases - The FAR-PEARL Study Report 1.

Kenneth C S Fong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.